Medivir to acquire Nordic speciality pharma company

Medivir AB has announced an offer to acquire the Nordic speciality pharmaceutical company, BioPhausia AB, in a cash and share offer that values BioPhausia at about SEK 565 million (€62 million). The offer was announced on 11 April 2011.